Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tacrolimus opthalmic - Novaliq

Next Previous
Drug Profile

Tacrolimus opthalmic - Novaliq

Alternative Names: BTQ-2401; NOV-05; NovaTac

Latest Information Update: 26 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novaliq
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antiglaucomas; Antipsoriatics; Antirheumatics; Eye disorder therapies; Lactones; Macrolides; Skin disorder therapies; Urologics; Vascular disorder therapies
  • Mechanism of Action Bone morphogenetic protein receptor type II modulators; Calcineurin inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Allergic conjunctivitis; Uveitis
  • Discontinued Plaque psoriasis

Most Recent Events

  • 11 Jul 2024 Preclinical trials in Allergic conjunctivitis in Germany (Ophthalmic) before July 2024 (Novaliq pipeline, July 2024))
  • 11 Jul 2024 Preclinical trials in Uveitis in Germany (Ophthalmic) before July 2024 (Novaliq pipeline, July 2024)
  • 22 Feb 2016 Discontinued - Phase-II for Plaque psoriasis in Germany (Topical)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top